Relaxo Footwears Ltd

- There is no explicit mention in the transcript of any current or future fundraising plans through debt or equity. - The company continues to be net debt free as of March 31, 2025. - Capex guidance for the next year is around INR 100 crores, funded through internal resources. - Management highlighted utilization of existing surplus capacity and ongoing investments in new articles, retail outlets, and energy-saving devices without indicating external fundraising. - The focus appears to be on improving operational efficiency and working capital management rather than raising external capital.

- The company plans a capex of around INR 100 crores for the next year. - Capex components include: - Cost for new molds for new articles (~INR 30 crores annually). - Opening of 50 new retail outlets, including modernization and Sparx exclusive stores. - Investment in energy-saving devices such as solar energy and fuel-efficient boilers to reduce long-term costs. - Some capital expenditure in project and office departments. - The company has surplus production capacity and intends to better utilize it, especially for export opportunities. - Investments will also support premiumization and new product launches. - The focus remains on operational efficiency and improving product mix alongside the capex.

- The company expects meaningful overall growth in the long term, primarily through premiumization, focusing more on high-value and premium products rather than volume growth. (Page 16) - Volume growth may be limited due to preference for premium articles as the lower segment faces pressure. (Page 16) - Top line growth is anticipated from H2 FY '26 onwards as the distribution model stabilizes and shifts focus from primary to secondary sales and retail expansion. (Pages 8, 13) - New retail outlets are planned to increase by about 5%, with 50 new retail outlets and Sparx exclusive stores addition targeted. (Page 11) - The company is targeting about 100 new distributors and increasing secondary sales through initiatives like the Relaxo Parivaar app. (Pages 12, 15) - Overall, sales growth may be moderate near-term due to external factors and channel transformation pains. (Pages 8, 16)

- The company expects overall growth primarily driven by premiumization rather than volume increase, focusing on higher-value products as the low-end segment faces pressure. - ROCE (Return on Capital Employed) is projected to improve by 2-3% in the coming years due to enhanced cost efficiency and better EBIT/EBITDA. - EBITDA margins are anticipated to improve, supported by backend operational efficiencies and cost controls, with a margin improvement target of around 100 bps or more. - Profitability and bottom-line growth are a focus, with expected improvement in both topline and margins as the distribution transformation and retail strategies mature. - Capex guidance is around INR 100 crores for the next year to support growth initiatives. - Despite near-term volume pressure due to restructuring and external factors, medium- to long-term earnings growth and EPS expansion are expected through improved product mix and operational efficiencies.

The transcript does not explicitly mention any current or expected order book or pending orders for Relaxo Footwears Limited. However, some related insights include: - Focus on improving secondary sales and quality of sales rather than pushing primary sales. - Distribution revamp ongoing, with expectations of improvement in sales volume from H2 FY '26 onwards. - Addition of around 100 new distributors and expansion of retail outlets by 5-10% planned. - Export opportunities, including exploration of the UK market, are being considered. - Overall sales growth expected to come from premiumization and improved mix rather than volume increase. - No direct or specific data on order book or pending orders were provided in the transcript.